These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36325887)

  • 1. Real-time assessment of positive and negative affective fluctuations and mood lability in a transdiagnostic sample of youth.
    Naim R; Shaughnessy S; Smith A; Karalunas SL; Kircanski K; Brotman MA
    Depress Anxiety; 2022 Dec; 39(12):870-880. PubMed ID: 36325887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder.
    Winters DE; Fukui S; Leibenluft E; Hulvershorn LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):298-305. PubMed ID: 29708762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive Mood Dysregulation Disorder in a Community Mental Health Clinic: Prevalence, Comorbidity and Correlates.
    Freeman AJ; Youngstrom EA; Youngstrom JK; Findling RL
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):123-30. PubMed ID: 26745325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruptive Mood Dysregulation Disorder Symptoms and Association with Oppositional Defiant and Other Disorders in a General Population Child Sample.
    Mayes SD; Waxmonsky JD; Calhoun SL; Bixler EO
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):101-6. PubMed ID: 26745442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the DSM-5 construct of Disruptive Mood Dysregulation Disorder and ICD-10 Mixed Disorder of Emotion and Conduct in the UK Longitudinal Assessment of Manic Symptoms (UK-LAMS) Study.
    Sagar-Ouriaghli I; Milavic G; Barton R; Heaney N; Fiori F; Lievesley K; Singh J; Santosh P
    Eur Child Adolesc Psychiatry; 2018 Sep; 27(9):1095-1104. PubMed ID: 29730721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Efficacy of Internet Gaming Disorder With Attention Deficit Hyperactivity Disorder and Emotional Dysregulaton.
    Chang CH; Chang YC; Cheng H; Tzang RF
    Int J Neuropsychopharmacol; 2020 Jun; 23(6):349-355. PubMed ID: 32047929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Household Food Insecurity Is Associated with Symptoms of Emotional Dysregulation in Children with Attention Deficit Hyperactivity Disorder: The MADDY Study.
    Hatsu IE; Eiterman L; Stern M; Lu S; Johnstone JM; Leung BMY; Srikanth P; Robinette L; Tost G; Odei JB; Gracious BL; Arnold LE
    Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
    Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
    J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and Neural Sustained Attention Deficits in Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder.
    Pagliaccio D; Wiggins JL; Adleman NE; Curhan A; Zhang S; Towbin KE; Brotman MA; Pine DS; Leibenluft E
    J Am Acad Child Adolesc Psychiatry; 2017 May; 56(5):426-435. PubMed ID: 28433092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM-5 disruptive mood dysregulation disorder: correlates and predictors in young children.
    Dougherty LR; Smith VC; Bufferd SJ; Carlson GA; Stringaris A; Leibenluft E; Klein DN
    Psychol Med; 2014 Aug; 44(11):2339-50. PubMed ID: 24443797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruptive mood dysregulation disorder at the age of 6 years and clinical and functional outcomes 3 years later.
    Dougherty LR; Smith VC; Bufferd SJ; Kessel EM; Carlson GA; Klein DN
    Psychol Med; 2016 Apr; 46(5):1103-14. PubMed ID: 26786551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide analysis of emotional lability in adult attention deficit hyperactivity disorder (ADHD).
    Gisbert L; Vilar L; Rovira P; Sánchez-Mora C; Pagerols M; Garcia-Martínez I; Richarte V; Corrales M; Casas M; Ramos-Quiroga JA; Soler Artigas M; Ribasés M
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):795-802. PubMed ID: 31085060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of disruptive mood dysregulation disorder in children with attention-deficit/hyperactivity disorder.
    Mulraney M; Silk TJ; Gulenc A; Efron D; Hazell P; Sciberras E
    J Affect Disord; 2021 Jan; 278():502-505. PubMed ID: 33017677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbid Internalizing and Externalizing Disorders Predict Lability of Negative Emotions Among Children With ADHD.
    Leaberry KD; Rosen PJ; Fogleman ND; Walerius DM; Slaughter KE
    J Atten Disord; 2020 Dec; 24(14):1989-2001. PubMed ID: 28992752
    [No Abstract]   [Full Text] [Related]  

  • 16. The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School.
    Baweja R; Belin PJ; Humphrey HH; Babocsai L; Pariseau ME; Waschbusch DA; Hoffman MT; Akinnusi OO; Haak JL; Pelham WE; Waxmonsky JG
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):154-63. PubMed ID: 26771437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study.
    Axelson D; Findling RL; Fristad MA; Kowatch RA; Youngstrom EA; Horwitz SM; Arnold LE; Frazier TW; Ryan N; Demeter C; Gill MK; Hauser-Harrington JC; Depew J; Kennedy SM; Gron BA; Rowles BM; Birmaher B
    J Clin Psychiatry; 2012 Oct; 73(10):1342-50. PubMed ID: 23140653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of emotional lability and emotional and behavioral difficulties among children with and without ADHD.
    Rosen PJ; Walerius DM; Fogleman ND; Factor PI
    Atten Defic Hyperact Disord; 2015 Dec; 7(4):281-94. PubMed ID: 25957599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation.
    Johnstone JM; Leung BMY; Srikanth P; Hatsu I; Perez L; Gracious B; Tost G; Aman MG; Gadow KD; Findling RL; Bukstein O; Arnold LE
    J Child Adolesc Psychopharmacol; 2020 Apr; 30(3):166-172. PubMed ID: 32101469
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.